Labcorp Holdings Inc.

LH Healthcare Diagnostics & Research

Labcorp Holdings Inc.’s revenue for fiscal 2025 (year ended December 2025) was $14.0 billion, up 7.25% from fiscal 2024. In the quarter to June 2026, revenue grew 5.78%, EPS grew 28.4%, free cash flow fell 42.0% and total debt rose 15.1%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for five consecutive years, revenue growth for three.

318.66 6.41 −1.97%
Market cap
$26.4B
P/E
26.2×
Fwd P/E
19.0×
Dividend yield
0.90%
F-score
8/9
Altman Z
3.02
Beneish M
−2.55
Dividend safety
74/100

Labcorp Holdings Inc. (LH) Operating cash flow

Alert me on Operating cash flow

Labcorp Holdings Inc.'s operating cash flow for fiscal 2025 was $1.6B, unchanged from fiscal 2024. Over the twelve months to 30 June 2026 it was $1.6B. Over the past ten years it has ranged from $982.4M (fiscal 2015) to $3.1B (fiscal 2021); the current reading is higher than 73% of that period. Labcorp Holdings Inc. ranks 5th of 52 Diagnostics & Research companies by operating cash flow.

Operating cash flow, annual

Embed this chart

Annual newest first

Period Operating cash flow Change
FY2025 $1.6B 3.45%
FY2024 $1.6B 19.44%
FY2023 $1.3B (32.12%)
FY2022 $2.0B (37.10%)
FY2021 $3.1B 45.63%
FY2020 $2.1B 47.80%
FY2019 $1.4B 10.67%
FY2018 $1.3B (12.86%)
FY2017 $1.5B 25.14%
FY2016 $1.2B 21.85%

Quarterly newest first

Period Operating cash flow Change
Jun 2026 $445.5M 132.64%
Mar 2026 $191.5M (68.82%)
Dec 2025 $614.2M 58.63%
Sep 2025 $387.2M (37.61%)
42 more quarters

Against its own ten years

Low $982.4M High $3.1B
Ten-year median $1.5B
Current reading's percentile 73

Operating cash flow against peers

What Operating cash flow is

Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.

Reported line item

The full definition of Operating cash flow →

More on LH